EFOI Q4 2024 Earnings Narrowed Loss Highlights Ongoing Restructuring Efforts HUBS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines NWN Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment